Situation

A pharmaceutical company experiencing significant turnover within its accounting team needed immediate support to stabilize its finance function. The company had not produced complete financial statements or reconciled its cash accounts since 2022, creating a significant historical backlog and limited visibility into its financial position.

At the same time, the company needed to reconcile and support reporting for a $30M+ grant while managing liquidity and an ongoing capital raise.

MMG was engaged to provide both hands-on accounting leadership and CFO-level financial support.

Solutions

Results

MMG restored the financial infrastructure management needed to operate with confidence. Historical accounting gaps were resolved, financial reporting was brought current, and recurring processes were established to prevent the company from falling back into the same position.

Management gained reliable visibility into cash, liquidity, and future funding needs, while stronger accounting processes improved the company’s ability to manage complex grant reporting requirements. With the day-to-day finance function stabilized, MMG’s CFO Advisory team could also focus on forward-looking priorities, including financial planning, funding scenarios, and support for the company’s ongoing capital raise.